Clinical characteristics of the 39 patients who received transplants
| . | . | Patients with ecGVHD, 22 . | Patients without cGVHD, 17 . |
|---|---|---|---|
| Recipient, age | 43 | 47 | 53 |
| Median, range | 17–70 | 22–70 | 17–68 |
| Recipient, gender | |||
| Male/female | 18/21 | 12/10 | 6/11 |
| Donor, age | 35 | 39.5 | 45.5 |
| Median, range | 11–71 | 24–69 | 11–71 |
| Donor, gender | |||
| Male/female | 21/18 | 12/10 | 9/8 |
| Diagnosis | |||
| ANLL/ALL/ | 11/3 | 6/1 | 5/2 |
| NHL/HL/MM | 5/1/3 | 1/0/3 | 4/1/0 |
| CML/CLL/MDS | 10/2/2 | 8/1/1 | 2/1/1 |
| Other | 2 | 1 | 1 |
| Status before transplantation | |||
| CR/PR | 13/12 | 6/7 | 7/5 |
| SD/PD | 3/11 | 1/8 | 2/3 |
| HLA-id. sibling/MUD/CB/ | 26/9/1 | 16/5/0 | 10/4/1 |
| HLA mismatch/HLA haplo. | 2/1 | 0/1 | 2/0 |
| Stem cell source | |||
| PBSC/BM/CB | 14/24/1 | 12/10/0 | 2/14/1 |
| Status | |||
| Alive/dead | 29/10 | 13/9 | 16/1 |
| Relapse | |||
| Yes/no | 11/28 | 8/14 | 3/14 |
| . | . | Patients with ecGVHD, 22 . | Patients without cGVHD, 17 . |
|---|---|---|---|
| Recipient, age | 43 | 47 | 53 |
| Median, range | 17–70 | 22–70 | 17–68 |
| Recipient, gender | |||
| Male/female | 18/21 | 12/10 | 6/11 |
| Donor, age | 35 | 39.5 | 45.5 |
| Median, range | 11–71 | 24–69 | 11–71 |
| Donor, gender | |||
| Male/female | 21/18 | 12/10 | 9/8 |
| Diagnosis | |||
| ANLL/ALL/ | 11/3 | 6/1 | 5/2 |
| NHL/HL/MM | 5/1/3 | 1/0/3 | 4/1/0 |
| CML/CLL/MDS | 10/2/2 | 8/1/1 | 2/1/1 |
| Other | 2 | 1 | 1 |
| Status before transplantation | |||
| CR/PR | 13/12 | 6/7 | 7/5 |
| SD/PD | 3/11 | 1/8 | 2/3 |
| HLA-id. sibling/MUD/CB/ | 26/9/1 | 16/5/0 | 10/4/1 |
| HLA mismatch/HLA haplo. | 2/1 | 0/1 | 2/0 |
| Stem cell source | |||
| PBSC/BM/CB | 14/24/1 | 12/10/0 | 2/14/1 |
| Status | |||
| Alive/dead | 29/10 | 13/9 | 16/1 |
| Relapse | |||
| Yes/no | 11/28 | 8/14 | 3/14 |
ecGVHD indicates extensive chronic graft-versus-host disease; ANLL, acute nonlymphoblastic leukemia; ALL, acute lymphoblastic leukemia; NHL, non-Hodgkin lymphoma; HL, Hodgkin lymphoma; MM, multiple myeloma; CML, chronic myelogenous leukemia; CLL, chronic lymphocytic leukemia; MDS, myelodysplastic syndrome; CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease; HLA-id. sibling, marrow from identical siblings; MUD, matched-unrelated donor; CB, cord blood; HLA mismatch, mismatched marrow from parents/siblings; HLA haplo, marrow from haploidentical parents/siblings; PBSC, peripheral blood stem cell; and BM, bone marrow.